Table 1.
Mouse model | Strain | Baseline | Disease state | References | |
---|---|---|---|---|---|
↔HW/BW | AS: ↔ HW/BW | ||||
AT2 TG mice (cardiomyocyte-specific, α-MHC) | C57BL/6 | ↑PW | Ang II: ↔ HW/BW, ↓HR | [15, 18, 19] | |
↑EF% | MI: ↔LVMI, ↑PW, ↑EF% | ||||
↑LVW/BW, | |||||
↓wall thickness | |||||
↑interstitial collagen | |||||
AT2highTG | ↑myocyte area and length | [14] | |||
AT2 TG mice (ventricular myocyte-specific, MLC-2v) | ↓LV contractile function | ||||
FVB/n | ↑apoptosis | ||||
AS: ↔LVW/BW | |||||
↔wall thickness | |||||
↓myocyte diameter | |||||
AT2lowTG | ↔ cardiac morphology and function | ↓interstitial collagen | [21] | ||
↓LVSP | |||||
↓LVEDP | |||||
↑BP | AS: No hypertrophy | ||||
↑HR | ↓interstitial collagen | ||||
↓LVW/BW | ↔cardiac function | ||||
AT2 KO mice | C57BL/6 | ↓wall thickness | Ang II: No hypertrophy | [16, 22, 23] | |
↓LVMI | ↔BP | ||||
↔contractile function | ↓interstitial collagen | ||||
↑diastolic function | |||||
↔BP | AS: ↔hypertrophy | ||||
↔ cardiac morphology | ↑perivascular fibrosis | ||||
AT2 KO mice | FVB/n | ↑coronary arterial thickening | |||
AMI: ↑LVW/BW | [17, 24, 25] | ||||
↑Lung/BW | |||||
↓EF% |
HW: heart weight; LVW: left ventricular weight; BP: blood pressure; HR: heart rate; LVMI: left ventricular mass index; PW: posterior wall thickness; EF: ejection fraction; AS: aortic stenosis; Ang II: Ang II infusion; MI: myocardial infarction.